Clinical Trial Update: Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of LEO 152020 in adults with cholinergic urticaria has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholinergic Urticaria

Drugs mentioned

• LEO 152020

Snippet

Sponsor: JW Pharmaceutical | Conditions: Cholinergic Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2024-03-21